Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
31,670,115
-
Shares change
-
+3,724,979
-
Total reported value, excl. options
-
$1,340,574,104
-
Value change
-
+$157,430,709
-
Put/Call ratio
-
47%
-
Number of buys
-
93
-
Number of sells
-
-56
-
Price
-
$42.32
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2021
179 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2021.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,670,115 shares
of 48,041,653 outstanding shares and own 65.92% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (7,566,292 shares), BlackRock Inc. (4,228,452 shares), VANGUARD GROUP INC (2,084,802 shares), GENEVA CAPITAL MANAGEMENT LLC (1,311,129 shares), MARSHALL WACE, LLP (1,292,244 shares), AMERIPRISE FINANCIAL INC (1,043,607 shares), STATE STREET CORP (1,004,331 shares), Ranger Investment Management, L.P. (877,902 shares), Invesco Ltd. (606,560 shares), and PALISADE CAPITAL MANAGEMENT LLC/NJ (584,301 shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.